Harmsen M, Li H, Sun S, van der Poel W, Dekker A
Front Vet Sci. 2023; 9:1040802.
PMID: 36699337
PMC: 9869066.
DOI: 10.3389/fvets.2022.1040802.
Liu W, Shao J, Zhang G, Chang Y, Ge S, Sun Y
J Clin Microbiol. 2020; 59(3).
PMID: 33328177
PMC: 8106706.
DOI: 10.1128/JCM.02464-20.
Shimmon G, Kotecha A, Ren J, Asfor A, Newman J, Berryman S
PLoS One. 2018; 13(8):e0201853.
PMID: 30114227
PMC: 6095514.
DOI: 10.1371/journal.pone.0201853.
Li P, Bai X, Sun P, Li D, Lu Z, Cao Y
BMC Vet Res. 2012; 8:57.
PMID: 22591597
PMC: 3488552.
DOI: 10.1186/1746-6148-8-57.
Szczepanek S, Barrette R, Rood D, Alejo D, Silbart L
Clin Vaccine Immunol. 2012; 19(4):461-7.
PMID: 22323558
PMC: 3318270.
DOI: 10.1128/CVI.00035-12.
Identification of cellular genes affecting the infectivity of foot-and-mouth disease virus.
Piccone M, Feng Y, Chang A, Mosseri R, Lu Q, Kutish G
J Virol. 2009; 83(13):6681-8.
PMID: 19369337
PMC: 2698527.
DOI: 10.1128/JVI.01729-08.
Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.
Duque H, Baxt B
J Virol. 2003; 77(4):2500-11.
PMID: 12551988
PMC: 141088.
DOI: 10.1128/jvi.77.4.2500-2511.2003.
Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates.
Haydon D, Bastos A, Knowles N, Samuel A
Genetics. 2001; 157(1):7-15.
PMID: 11139487
PMC: 1461471.
DOI: 10.1093/genetics/157.1.7.
High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit.
Neff S, Mason P, Baxt B
J Virol. 2000; 74(16):7298-306.
PMID: 10906183
PMC: 112250.
DOI: 10.1128/jvi.74.16.7298-7306.2000.
VP1-coding sequences of recent isolates of foot-and-mouth disease virus types A, O and Asia1.
Marquardt O, Haas B
Virus Genes. 1998; 16(2):185-93.
PMID: 9608664
DOI: 10.1023/a:1007968007117.
Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure.
Haydon D, Lea S, Fry L, Knowles N, Samuel A, Stuart D
J Mol Evol. 1998; 46(4):465-75.
PMID: 9541542
DOI: 10.1007/pl00006327.
Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.
Tami C, Kaplan G, Piccone M, Palma E
Virus Genes. 1997; 14(3):255-9.
PMID: 9311571
DOI: 10.1023/a:1007996213037.
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.
Rieder E, Baxt B, Rodarte R, Tanuri A, Mason P
J Virol. 1997; 71(7):5115-23.
PMID: 9188578
PMC: 191746.
DOI: 10.1128/JVI.71.7.5115-5123.1997.
Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
Mateu M, Hernandez J, Martinez M, Feigelstock D, Lea S, Perez J
J Virol. 1994; 68(3):1407-17.
PMID: 8107204
PMC: 236594.
DOI: 10.1128/JVI.68.3.1407-1417.1994.
Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV.
Rieder E, Baxt B, Lubroth J, Mason P
J Virol. 1994; 68(11):7092-8.
PMID: 7523697
PMC: 237147.
DOI: 10.1128/JVI.68.11.7092-7098.1994.
Development of foot-and-mouth disease virus strain characterisation--a review.
Kitching R, Knowles N, Samuel A, Donaldson A
Trop Anim Health Prod. 1989; 21(3):153-66.
PMID: 2552629
DOI: 10.1007/BF02250825.
Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus.
Mateu M, Martinez M, Rocha E, Andreu D, Parejo J, Giralt E
Proc Natl Acad Sci U S A. 1989; 86(15):5883-7.
PMID: 2474821
PMC: 297735.
DOI: 10.1073/pnas.86.15.5883.
Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.
Baxt B, Vakharia V, Moore D, Franke A, MORGAN D
J Virol. 1989; 63(5):2143-51.
PMID: 2467993
PMC: 250631.
DOI: 10.1128/JVI.63.5.2143-2151.1989.
Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies.
Neyt C, Geliebter J, Slaoui M, Morales D, Meulemans G, Burny A
J Virol. 1989; 63(2):952-4.
PMID: 2463386
PMC: 247772.
DOI: 10.1128/JVI.63.2.952-954.1989.
Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.
Kitson J, Burke K, Pullen L, Belsham G, Almond J
J Virol. 1991; 65(6):3068-75.
PMID: 1709696
PMC: 240962.
DOI: 10.1128/JVI.65.6.3068-3075.1991.